.png)
Journal of Multiscale Neuroscience
ISSN: 2653-4983
%20(1200%20x%201700%20px)%20(13).jpg)
At a Glance
Abbrev.: J. Multisc. Neurosci. Established : 2021 First Issue : 2022 Frequency : 4 issues/yr Diamond Model: Open Access Scope: Neuroscience
The Journal of Multiscale Neuroscience is committed to advancing the field through a transdisciplinary framework, uniting multiscale, integrative, and interdisciplinary approaches to brain science. The Journal provides a platform for research that bridges submolecular, molecular, cellular, systems, and cognitive levels of organization, fostering a deeper understanding of how complex neural phenomena arise across interacting scales. It particularly welcomes contributions that move beyond reductionist or single-scale models, emphasizing relational, dynamical, and process-based accounts of brain function. By promoting conceptual innovation alongside rigorous empirical and theoretical work, the Journal aims to support the development of next-generation frameworks for understanding brain organization, cognition, and consciousness.
Median number of days from submission to first decision
6 Days ⓘ
First decision
Median days from submission to first editor decision.
39 Days ⓘ
Review time
Median days from acceptance to first online publication.
15 Days ⓘ
Publication
Open Access
24 Jun 2026
Clinical Case Report
Acute right brainstem infarction complicated by decompensated liver cirrhosis, coagulopathy, and progressive thrombocytopenia
Lang Jiayu, Zhao Miaomiao, Zheng Xin, Zhang Sumei
Open Access
27 Jun 2026
Perspective
From bioinformatics to translational neuroscience: computational modeling at the frontier of drug discovery
Filippo Dall'Armellina
Open Access
29 Jun 2026
Original Research
Mutations of TARDBP gene: conformational changes of TDP43 protein occurring in Amyotrophic Lateral Sclerosis disease
Martina Cerrato, Laura D’Aiello, Alessandra Darino, Elisa Maria Gatti, Fabio Persia, Jack A. Tuszynski
Open Access
27 Jun 2026
Brief Report
Characterization of kinase inhibitors targeting MAP tau hyperphosphorylation as potential therapeutic agents for Alzheimer’s disease
Matilde Ercole and Jack A. Tuszynski